bupropion targets nicotine
Evidence from:
primary |
all sources
Evidence (1 sources)
Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation.
(2008)
PMID:18593715
cited
Bupropion ... is among the only two FDA-approved non-nicotine pharmacotherapies available for the treatment of nicotine dependence.
confidence: 0.95